FO
FT Options Portfolio holdings
AUM
$40M
This Quarter Return
-9.93%
1 Year Return
+13.03%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$61.8M
AUM Growth
+$61.8M
(-39%)
Cap. Flow
-$31.2M
Cap. Flow
% of AUM
-50.43%
Top 10 Holdings %
Top 10 Hldgs %
60.14%
Holding
194
New
38
Increased
14
Reduced
17
Closed
42
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$9.29M |
| 2 |
Baxter International
BAX
|
$4.11M |
| 3 |
Akebia Therapeutics
AKBA
|
$3.19M |
| 4 |
OTIC
Otonomy, Inc.
OTIC
|
$2.33M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$1.97M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$8.99M |
| 2 |
CELG
Celgene Corp
CELG
|
$6.57M |
| 3 |
DYAX
DYAX CORPORATION
DYAX
|
$6.35M |
| 4 |
Chipotle Mexican Grill
CMG
|
$5.39M |
| 5 |
DuPont de Nemours
DD
|
$2.64M |
Sector Composition
| 1 | Healthcare | 74.85% |
| 2 | Technology | 6.27% |
| 3 | Consumer Discretionary | 3.87% |
| 4 | Consumer Staples | 2.68% |
| 5 | Materials | 2.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Regeneron Pharmaceuticals
REGN
$61.5B
| $12M | 12.52% |
33,159
+25,769
| +349% | +$9.29M |
|
2
Abbott
ABT
$231B
| $5.66M | 5.93% |
135,300
+13,000
| +11% | +$544K |
|
|
3
Baxter International
BAX
$12.7B
| $4.11M | 4.3% |
+100,000
| New | +$4.11M |
|
|
4
Akebia Therapeutics
AKBA
$833M
| $3.51M | 3.68% |
389,919
+353,763
| +978% | +$3.19M |
|
|
5
Gilead Sciences
GILD
$140B
| $2.52M | 2.64% |
27,390
-97,843
| -78% | -$8.99M |
|
|
OTIC
6
DELISTED
Otonomy, Inc.
OTIC
| $2.33M | 2.44% |
+156,437
| New | +$2.33M |
|
|
ICPT
7
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.97M | 2.06% |
+15,314
| New | +$1.97M |
|
|
ALR
8
DELISTED
Alere Inc
ALR
| $1.83M | 1.92% |
+36,163
| New | +$1.83M |
|
|
MDVN
9
DELISTED
MEDIVATION, INC.
MDVN
| $1.75M | 1.84% |
+38,155
| New | +$1.75M |
|
10
IBM
IBM
$227B
| $1.52M | 1.59% |
10,012
-3,621
| -27% | -$548K |
|
|
CMRX
11
DELISTED
Chimerix, Inc.
CMRX
| $1.47M | 1.54% |
287,712
+133,612
| +87% | +$683K |
|
|
CASC
12
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.29M | 1.35% |
1,015,607
+715,596
| +239% | +$909K |
|
13
Rocket Pharmaceuticals
RCKT
$354M
| $1.26M | 1.31% |
169,551
+143,130
| +542% | +$1.06M |
|
14
Humana
HUM
$36.5B
| $1.2M | 1.26% |
6,578
-9,357
| -59% | -$1.71M |
|
15
Cal-Maine
CALM
$5.61B
| $1.19M | 1.24% |
22,892
-6,162
| -21% | -$320K |
|
|
POT
16
DELISTED
Potash Corp Of Saskatchewan
POT
| $1.02M | 1.07% |
60,000
-40,000
| -40% | -$681K |
|
|
17
Chipotle Mexican Grill
CMG
$56.5B
| $930K | 0.97% |
1,974
-11,439
| -85% | -$5.39M |
|
18
Expedia Group
EXPE
$26.6B
| $914K | 0.96% |
+8,481
| New | +$914K |
|
|
TWC
19
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $849K | 0.89% |
+4,151
| New | +$849K |
|
|
ADT
20
DELISTED
ADT CORP
ADT
| $806K | 0.84% |
+19,541
| New | +$806K |
|
|
BXLT
21
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $795K | 0.83% |
+19,673
| New | +$795K |
|
22
SPDR S&P Biotech ETF
XBI
$5.07B
| $775K | 0.81% |
+15,000
| New | +$775K |
|
23
Pfizer
PFE
$141B
| $643K | 0.67% |
21,686
+3,616
| +20% | +$107K |
|
|
FPRX
24
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $622K | 0.65% |
15,312
+4,807
| +46% | +$195K |
|
|
EMC
25
DELISTED
EMC CORPORATION
EMC
| $600K | 0.63% |
22,500
+12,500
| +125% | +$333K |
|